Jama Oncology

At JAMA Oncology, our primary goal is to contribute to the advancement of oncology research and enhance patient care. As a leading journal in the field, we strive to publish influential original research, opinions, and reviews that push the boundaries of oncology science. Our mission is to serve as the definitive resource for scientists, clinicians, and trainees in oncology globally. Through our innovative and timely scientific and educational content, we aim to provide a comprehensive understanding of cancer pathogenesis and the latest treatment advancements to our readers. We are dedicated to effectively disseminating the findings of significant clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our ultimate objective is to facilitate the translation of new knowledge into tangible clinical benefits for individuals living with and surviving cancer.

JAMA Oncology（《美国医学会肿瘤学杂志》）每周在线出版，且每周四出版，每年出版12期印刷/在线期刊。该杂志每年的文章浏览量和下载量超过640万次。无需任何作者费用，所有研究文章在网站上发表12个月后即可免费在线访问。此外，通过世界卫生组织的HINARI计划，发展中国家的机构可以免费或几乎免费获得在线版本。JAMA Oncology是JAMA Network的成员，该网络是一个由同行评审的普通医学和专业出版物组成的联盟。该期刊的接受率为13%。首次决定的中位时间为2天，审查时间为50天。该期刊的影响因子为28.4，是肿瘤学期刊中排名最高的期刊之一。所有文章首先在线发布。该期刊致力于发表有影响力的原创研究、观点和评论，推动肿瘤科学的发展，其使命是成为全球肿瘤学科学家、临床医生和受训人员的权威资源。